查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1912608

血液储存设备市场按产品类型、储存方式、应用和最终用户划分 - 全球预测 2026-2032 年

Blood Storage Equipment Market by Product Type, Storage Mode, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血液储存设备市场价值将达到 15.1 亿美元，到 2026 年将成长到 16 亿美元，到 2032 年将达到 25.8 亿美元，年复合成长率为 7.95%。

关键市场统计数据
基准年 2025 15.1亿美元
预计年份：2026年 16亿美元
预测年份 2032 25.8亿美元
复合年增长率 (%) 7.95%

全面介绍由临床需求、技术创新、供应链变革和监管发展所驱动的血液储存设备变革趋势。

由于技术、监管和物流等多方面因素的共同作用，血液储存设备的临床和营运环境已进入持续变革时期期。医院、血库、诊断检查室和研究实验室都在应对日益复杂的温控储存、可追溯性和长期样本完整性要求。低温技术的进步、低温运输可视性的提升以及对合规性的日益重视，共同促使血液储存设备成为整体医疗基础设施规划中的策略组成部分。

变革性的变化正在重塑血液储存方式，包括低温技术、自动化、远端监控和医疗保健供应实践的创新。

医疗机构在采购、部署和管理血液储存设备方面正经历多项变革，这些变革正在重塑医疗机构的运作方式。首先，数位化和远端监控能力已超越了基本的警报系统，涵盖了连续温度记录、预测性维护警报以及安全的云端审核追踪，这些功能有助于符合监管要求并实现快速事件响应。这种互联互通降低了检体污染的风险，并实现了跨多个机构的集中管理，从而提高了营运效率和临床可靠性。

2025年美国关税对血库设备供应链、筹资策略及供应商关係的累积影响

到2025年，影响进口医疗设备的关税措施对筹资策略、供应链弹性计画和供应商谈判产生了累积影响。传统上依赖跨境采购的组织正在重新评估其对总到岸成本的考量，包括关税风险、海关延误和紧急库存持有成本。采购团队正越来越多地探索多源采购策略和本地服务协议，以减轻贸易政策波动可能带来的潜在干扰。

关键细分市场洞察揭示了影响采购选择和技术采用模式的产品、储存、最终用户和应用趋势

细分市场层面的趋势揭示了不同产品、储存模式、最终用户和应用领域中不同的采购驱动因素和技术需求。产品类型分析区分了血库储存系统、超低温储存系统、血浆冷冻库和冷藏库，每种产品在资本密集度、维护特性和监管合规要求方面均有所不同。血库储存系统优先考虑吞吐量、可追溯性和快速存取工作流程，而超低温系统则强调超低温稳定性和专门的通讯协定。血浆冷冻库需要均匀的温度分布和可靠的除霜循环，而冷藏库优先考虑能源效率和稳定的冷却性能之间的平衡，以满足常规检体储存的需求。

美洲、欧洲、中东和非洲以及亚太地区的区域背景和挑战对物流、法规和临床需求产生影响。

区域趋势对美洲、欧洲、中东和非洲以及亚太地区的设备选择、服务模式和监管协调有显着影响。每个地区的临床需求模式和物流挑战各不相同。在美洲，大规模综合医疗系统和国家血液服务机构通常优先考虑扩充性的解决方案，这些方案需具备强大的供应商服务网络，并能与电子健康记录系统互通性。供应链的韧性和零件的快速供应是常见的采购标准，而区域内的製造能力则有助于缩短关键子系统的前置作业时间。

血液银行设备产业主要企业的概况和策略方向，包括其创新重点、伙伴关係关係和全球生产基地。

血液储存设备领域的主要企业展现出清晰的策略方针，指导其市场定位和创新重点。一些供应商专注于拓展产品线，提供涵盖冷藏储存设备、血浆冷冻库和低温系统的产品组合。另一些供应商则强调在超低温解决方案或整合数位监控服务等细分领域的领先地位。所有企业都呈现出一个通用的趋势，即转向全生命週期参与。製造商正在扩展其服务范围、保固范围、远距离诊断和培训项目，以在整体价值而非价格竞争力方面脱颖而出。

为产业领导者提供切实可行的建议，以增强韧性、加速智慧储存的普及应用，并优化采购和资产生命週期管理。

产业领导者应推行一系列切实可行、影响深远的倡议，以增强韧性并加速先进储存解决方案的普及。首先，应优先建构一个采购框架，该框架应包含基于场景的总成本分析，涵盖维护、服务回应时间和潜在的贸易政策影响。在合约中增加柔软性，例如签订多年服务协议、备件寄售协议以及明确的升级流程，可以降低营运风险并支援可预测的预算编制。

调查方法概述了应用于血液储存设备市场的资料来源、相关人员访谈、检验通讯协定和分析框架。

本调查方法整合了多种资料来源和系统性的检验通讯协定，以确保研究结果的可靠性和适用性。主要资料来源包括对采购人员、实验室主任、医学技师和临床终端使用者的访谈，以了解实际操作中面临的挑战、选择标准和维护经验。二级资讯来源包括监管指南、技术标准、产品资料和同行评审文献，以阐明性能预期和合规义务的具体情况。

总结了血液储存设备生态系统中相关人员的策略意义、营运重点和创新路径的结论

对临床优先事项、技术发展和营运限制的综合分析表明，血液储存设备相关人员正面临一个策略转折点。采用具备强大远端监控能力和服务生态系统的互操作系统的机构，将在加强合规管理、降低检体风险和应对不断扩展的临床应用方面获得优势。同时，将产品开发与生命週期服务交付和区域支援模式结合的供应商，将实现更高的客户维繫和更短的采用週期。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的血液储存设备市场

  • 血库储存系统
  • 冷冻保存系统
  • 等离子冷冻库
  • 冷藏库

第九章 依保存方式分類的血液保存设备市场

  • 低温储存
    • 液相
    • 气相
  • 冷冻储存
  • 冷藏库

第十章 血液保存设备市场：依应用领域划分

  • 血液成分保存
  • 血浆保存
  • 血小板储存
  • 干细胞保存

第十一章 依最终用户分類的血液储存设备市场

  • 血库
  • 诊断检查室
  • 医院
  • 研究所

第十二章 血液保存设备市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 血液储存设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国血液储存设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国血液储存设备市场

第十六章 中国血液储存设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arctiko A/S
  • B Medical Systems sal
  • Binder GmbH & Co. KG
  • Haier Biomedical Co., Ltd.
  • Helmer Scientific Inc.
  • PHC Holdings Corporation
  • StemCyte Inc.
  • Stirling Ultracold, LLC
  • Terumo Corp.
  • Thermo Fisher Scientific Inc.
  • Vita 34 AG
Product Code: MRR-AE420CB13A59

The Blood Storage Equipment Market was valued at USD 1.51 billion in 2025 and is projected to grow to USD 1.60 billion in 2026, with a CAGR of 7.95%, reaching USD 2.58 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.51 billion
Estimated Year [2026] USD 1.60 billion
Forecast Year [2032] USD 2.58 billion
CAGR (%) 7.95%

Comprehensive introduction to the changing blood storage equipment landscape driven by clinical needs, tech innovation, supply chain shifts, and regulation

The clinical and operational landscape for blood storage equipment has entered a period of sustained transformation driven by converging technological, regulatory, and logistical pressures. Hospitals, blood banks, diagnostic laboratories, and research institutes are navigating increasingly complex requirements for temperature-controlled storage, traceability, and long-term sample integrity. Advances in cryogenic techniques, improvements in cold-chain visibility, and a stronger emphasis on compliance have combined to elevate the strategic importance of storage equipment within broader healthcare infrastructure planning.

Stakeholders now demand solutions that not only preserve biological viability but also integrate with laboratory information systems and enterprise asset management platforms. Procurement teams are balancing total cost of ownership considerations against resilience imperatives such as redundancy, maintenance frequency, and emergency power tolerance. At the same time, research institutions and specialized centers are pushing the envelope on ultra-low temperature storage capabilities to support stem cell and regenerative medicine programs. Consequently, product roadmaps and vendor selection criteria have shifted from a pure capital-equipment orientation to a lifecycle-driven dialogue that prioritizes interoperability, data integrity, and service continuity.

Transformative shifts reshaping blood storage equipment including cryogenic breakthroughs, automation, remote monitoring, and supply practices in healthcare

Several transformative shifts are reshaping how healthcare organizations source, deploy, and manage blood storage equipment. First, digitalization and remote monitoring capabilities have progressed beyond basic alarm systems to include continuous temperature logging, predictive maintenance alerts, and secure cloud-based audit trails that support regulatory compliance and rapid incident response. This interconnectivity reduces the risk of sample compromise and enables centralized oversight across multiple facilities, enhancing operational efficiency and clinical confidence.

Second, cryogenic innovation has delivered materials, insulation, and cooling system refinements that extend sample lifetimes and reduce energy consumption. Concurrently, modular design principles and automation are enabling higher-density storage with more predictable retrieval times, which is critical for high-throughput blood banks and research biobanks. Third, supply chain dynamics-including regional manufacturing footprints, component lead times, and logistics constraints-are prompting procurement teams to prioritize vendors that can demonstrate resilient distribution and local service capabilities. Finally, policy and regulatory changes have reinforced the need for validated storage solutions, harmonized QA protocols, and robust documentation to satisfy accreditation and audit demands, thereby accelerating the adoption of standardized equipment and vendor consolidation in certain segments.

Cumulative implications of United States tariff measures in 2025 on blood storage equipment supply chains, procurement strategies, and vendor relationships

In 2025, tariff actions affecting imported medical equipment have had a cumulative impact on procurement strategies, supply chain resilience planning, and vendor negotiations. Organizations that historically relied on cross-border sourcing have re-evaluated total landed cost considerations to include tariff exposure, customs delays, and contingency inventory holdings. Procurement teams have increasingly sought multi-sourcing strategies and local-service agreements to mitigate potential disruptions stemming from trade policy volatility.

These developments underline the importance of transparent cost modeling and contractual flexibility. Contract terms are evolving to include clearer escalation clauses, manufacturer-supplied service commitments, and collaborative repair networks to reduce downtime risk. For capital-intensive purchases such as cryogenic storage systems and high-performance plasma freezers, lifecycle cost analysis is now being augmented with scenario planning that models tariff-driven price variability. At the same time, partnerships between vendors and regional distributors have become more strategic, focusing on local assembly, spare-parts warehousing, and certified service technicians to preserve uptime and regulatory compliance under changing trade regimes.

Key segmentation insights revealing product, storage mode, end user, and application dynamics that influence procurement choices and technology adoption patterns

Segment-level dynamics reveal distinct procurement drivers and technology needs across product, storage mode, end user, and application lenses. Product Type analysis differentiates blood bank storage systems, cryogenic storage systems, plasma freezers, and refrigerators, each presenting different capital intensity, maintenance profiles, and regulatory validation requirements. Blood bank storage systems prioritize throughput, traceability, and rapid access workflows, whereas cryogenic systems emphasize ultra-low temperature stability and specialized handling protocols. Plasma freezers demand uniform temperature distribution and reliable defrost cycles, while refrigerators balance energy efficiency with consistent refrigeration for routine sample holdings.

Storage Mode segmentation shows that cryogenic storage, frozen storage, and refrigerated storage each impose unique infrastructure and service demands. Cryogenic Storage further divides into liquid phase and vapor phase modalities, with liquid phase offering higher thermal capacity but requiring stringent handling protocols, and vapor phase delivering safer sample isolation with different maintenance implications. Frozen storage workflows hinge on reliable freeze-thaw cycles and temperature ramp control, while refrigerated storage focuses on maintaining narrow temperature bands and minimizing thermal excursions during frequent door openings.

Looking through the End User perspective, blood banks, diagnostic laboratories, hospitals, and research institutes exhibit different procurement cadences, validation requirements, and service expectations. Blood banks often emphasize high-volume, rapid-turnover solutions that integrate with donor management systems. Diagnostic laboratories prioritize throughput and sample traceability across multiple assay platforms. Hospitals seek versatile systems that support clinical workflows across transfusion services and pathology, while research institutes require highly controlled environments suited to long-term sample integrity and specialized experiments.

Application segmentation-blood component storage, plasma storage, platelet storage, and stem cell storage-drives nuanced requirements in temperature control, container compatibility, and monitoring granularity. Blood component storage demands strict separation and labeling workflows; plasma storage needs consistent subzero temperatures and validated thawing protocols; platelet storage requires controlled agitation and near-ambient cold storage solutions; and stem cell storage pushes the limits of ultra-low temperature cryogenic solutions with an emphasis on minimal thermal fluctuation and rigorous chain-of-custody documentation. Taken together, these segmentation perspectives underscore that procurement decisions are increasingly shaped by an intersection of functional performance, integration capability, service footprint, and regulatory validation pathways.

Regional context and challenges across the Americas, Europe Middle East and Africa, and Asia-Pacific influencing logistics, regulation, and clinical demand

Regional dynamics materially influence equipment selection, service models, and regulatory alignment across the Americas, Europe Middle East and Africa, and Asia-Pacific, each presenting a distinct mix of clinical demand patterns and logistical challenges. In the Americas, large integrated healthcare systems and national blood services often prioritize scalable solutions with strong vendor service networks and interoperability with electronic health records. Supply chain resilience and rapid parts availability are common procurement criteria, and regional manufacturing capabilities can accelerate lead times for critical subsystems.

Europe Middle East and Africa encompasses highly heterogeneous regulatory environments and infrastructure maturity levels. In several European markets, stringent regulatory harmonization and accreditation standards favor validated systems with robust documentation and lifecycle support. The Middle East and Africa region displays diverse procurement models where local distributors and service partners play an outsized role, and systems that permit flexible installation and remote diagnostics are particularly valued. Across this combined region, cross-border logistics and customs processes often influence decisions around spare parts inventory and local technician training.

Asia-Pacific presents a combination of rapid capacity expansion in healthcare and variable regulatory harmonization across jurisdictions. Demand for modular, scalable systems that support high-throughput blood banks and growing research biobanks is rising. Local manufacturing and regional assembly options are increasingly important to reduce exposure to lead-time variability, while remote monitoring and tele-service capabilities address maintenance constraints in more distributed geographies. Collectively, these regional factors drive differentiated strategies for vendor selection, service contracts, and capital planning.

Profiles and strategic direction of leading companies in blood storage equipment covering innovation focus, partnerships, and global production footprints

Leading companies in the blood storage equipment space demonstrate distinct strategic approaches that signal their market positioning and innovation priorities. Some vendors concentrate on product-line breadth, offering a portfolio that spans refrigerated storage, plasma freezers, and cryogenic systems, while others emphasize niche leadership in ultra-low temperature solutions or integrated digital monitoring services. Across profiles, a common thread is a shift toward lifecycle engagement: manufacturers are expanding service offerings, warranties, remote diagnostics, and training programs to differentiate on total value rather than price alone.

Partnership models and distribution networks also reflect strategic choices. Several firms pursue direct engagement with large health systems and centralized laboratories, delivering bundled solutions that include installation, validation, and long-term service agreements. Others leverage distributor partnerships to access fragmented or emerging markets, enabling local after-sales support and faster parts provisioning. Manufacturing and production footprints are optimized to balance cost-competitive assembly with proximity to key regional markets, thereby reducing lead times and tariff exposure. In parallel, vendors increasingly collaborate with software providers and laboratory automation firms to deliver interoperable ecosystems that enhance sample traceability and support regulatory documentation requirements.

Actionable recommendations for industry leaders to boost resilience, speed smart storage adoption, and optimize procurement and asset lifecycle management

Industry leaders should pursue a set of pragmatic, high-impact actions to strengthen resilience and accelerate adoption of advanced storage solutions. First, prioritize procurement frameworks that incorporate scenario-based total cost analysis covering maintenance, service response times, and potential trade policy impacts. Embedding flexibility into contracts-such as multi-year service commitments, spare-parts consignment arrangements, and clearly defined escalation paths-reduces operational risk and supports predictable budgeting.

Second, accelerate integration of digital monitoring and predictive maintenance technologies. Deploying systems that support continuous temperature verification, automated alerting, and secure remote access can materially reduce sample loss incidents and lower maintenance costs. Third, build stronger regional service capabilities through distributor partnerships, local technician certification programs, and regional parts depots to shorten repair cycles and protect uptime. Fourth, standardize validation and documentation practices across sites to streamline audits and accreditation processes, ensuring that new equipment installations meet clinical and regulatory expectations. Finally, invest in vendor collaboration for tailored solutions-co-developed hardware-software packages, bundled training, and joint contingency planning-that align with institutional clinical priorities and enable faster adoption of high-value storage technologies.

Research methodology outlining data sources, stakeholder interviews, validation protocols, and analytical frameworks applied to blood storage equipment market

The research methodology integrates multiple data sources and structured validation protocols to ensure the reliability and applicability of insights. Primary inputs include stakeholder interviews with procurement leaders, laboratory directors, biomedical engineers, and clinical end users, capturing real-world operational challenges, selection criteria, and maintenance experiences. Secondary sources comprise regulatory guidance, technical standards, product literature, and peer-reviewed literature that contextualize performance expectations and compliance obligations.

Analytical frameworks applied in the study include qualitative trend synthesis, comparative vendor profiling, and scenario-based procurement analysis. Data validation occurs through triangulation-cross-referencing interview findings with documented performance claims and service records-and through iterative review cycles with subject-matter experts to resolve discrepancies. The approach emphasizes transparency in methodological assumptions and documents limitations where data granularity for specialized applications (such as stem cell cryopreservation protocols) varies by institution.

Conclusion synthesizing strategic implications, operational priorities, and innovation pathways for stakeholders in blood storage equipment ecosystems

The synthesis of clinical priorities, technology evolution, and operational constraints points to a strategic inflection for blood storage equipment stakeholders. Organizations that adopt interoperable systems with strong remote monitoring and service ecosystems will be better positioned to manage compliance, reduce sample risk, and support expanding clinical applications. Simultaneously, vendors that align product development with lifecycle service offerings and regional support models will improve customer retention and reduce time-to-deployment friction.

Looking ahead, the interplay between cryogenic innovation, digitalization, and supply chain resilience will drive differentiated outcomes across end users and regions. Decision-makers should therefore evaluate equipment investments not only for immediate performance but also for their capacity to integrate into broader digital and clinical workflows, support regulatory scrutiny, and withstand logistical shocks. By synthesizing these considerations into procurement and operational plans, stakeholders can enhance clinical outcomes, protect biological assets, and create a foundation for scalable laboratory and transfusion services.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Storage Equipment Market, by Product Type

  • 8.1. Blood Bank Storage Systems
  • 8.2. Cryogenic Storage Systems
  • 8.3. Plasma Freezers
  • 8.4. Refrigerators

9. Blood Storage Equipment Market, by Storage Mode

  • 9.1. Cryogenic Storage
    • 9.1.1. Liquid Phase
    • 9.1.2. Vapor Phase
  • 9.2. Frozen Storage
  • 9.3. Refrigerated Storage

10. Blood Storage Equipment Market, by Application

  • 10.1. Blood Component Storage
  • 10.2. Plasma Storage
  • 10.3. Platelet Storage
  • 10.4. Stem Cell Storage

11. Blood Storage Equipment Market, by End User

  • 11.1. Blood Banks
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Blood Storage Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Blood Storage Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Blood Storage Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Blood Storage Equipment Market

16. China Blood Storage Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arctiko A/S
  • 17.6. B Medical Systems s.a.l.
  • 17.7. Binder GmbH & Co. KG
  • 17.8. Haier Biomedical Co., Ltd.
  • 17.9. Helmer Scientific Inc.
  • 17.10. PHC Holdings Corporation
  • 17.11. StemCyte Inc.
  • 17.12. Stirling Ultracold, LLC
  • 17.13. Terumo Corp.
  • 17.14. Thermo Fisher Scientific Inc.
  • 17.15. Vita 34 AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD STORAGE EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANK STORAGE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANK STORAGE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANK STORAGE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA FREEZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA FREEZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA FREEZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY LIQUID PHASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY LIQUID PHASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY LIQUID PHASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY VAPOR PHASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY VAPOR PHASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY VAPOR PHASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY FROZEN STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY FROZEN STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY FROZEN STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATED STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATED STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REFRIGERATED STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COMPONENT STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COMPONENT STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COMPONENT STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLASMA STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLATELET STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLATELET STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PLATELET STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STEM CELL STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STEM CELL STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STEM CELL STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 117. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. GCC BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. G7 BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 141. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NATO BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY STORAGE MODE, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY CRYOGENIC STORAGE, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA BLOOD STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)